ABVC
Price:
$1.19
Market Cap:
$17.24M
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-170...[Read more]
Industry
Biotechnology
IPO Date
2004-11-10
Stock Exchange
NASDAQ
Ticker
ABVC
According to ABVC BioPharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.05. This represents a change of -40.08% compared to the average of -5.09 of the last 4 quarters.
The mean historical PE Ratio of ABVC BioPharma, Inc. over the last ten years is -26.24. The current -3.05 PE Ratio has changed 1.06% with respect to the historical average. Over the past ten years (40 quarters), ABVC's PE Ratio was at its highest in in the December 2024 quarter at 8.57. The PE Ratio was at its lowest in in the December 2016 quarter at -501.16.
Average
-26.24
Median
-8.44
Minimum
-100.04
Maximum
-0.65
Discovering the peaks and valleys of ABVC BioPharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 345.87%
Maximum Annual PE Ratio = -0.65
Minimum Annual Increase = -99.70%
Minimum Annual PE Ratio = -100.04
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -6.26 | 345.87% |
| 2024 | -1.40 | 117.54% |
| 2023 | -0.65 | -46.41% |
| 2022 | -1.21 | -81.78% |
| 2021 | -6.62 | -35.58% |
| 2020 | -10.27 | -51.09% |
| 2019 | -21.00 | -72.63% |
| 2018 | -76.71 | -23.32% |
| 2017 | -100.04 | 161.19% |
| 2016 | -38.30 | -99.70% |
The current PE Ratio of ABVC BioPharma, Inc. (ABVC) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.77
5-year avg
-3.23
10-year avg
-26.24
ABVC BioPharma, Inc.’s PE Ratio is less than Reviva Pharmaceuticals Holdings, Inc. (-0.29), greater than Grace Therapeutics, Inc. (-4.57), less than LAVA Therapeutics N.V. (-2.01), less than PDS Biotechnology Corporation (-1.75), less than Actinium Pharmaceuticals, Inc. (-1.34), less than Jupiter Neurosciences, Inc. (-0.92), less than Tvardi Therapeutics, Inc. (-1.60), less than FibroGen, Inc. (0.18), less than Lantern Pharma Inc. (-2.74), greater than Xilio Therapeutics, Inc. (-43.40),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.29 | $2.33M | |
| -4.57 | $34.04M | |
| -2.01 | $45.77M | |
| -1.75 | $58.61M | |
| -1.34 | $31.69M | |
| -0.92 | $8.72M | |
| -1.60 | $24.77M | |
| 0.18 | $36.69M | |
| -2.74 | $49.50M | |
| -43.40 | $54.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABVC BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ABVC BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ABVC BioPharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for ABVC BioPharma, Inc. (ABVC)?
What is the highest PE Ratio for ABVC BioPharma, Inc. (ABVC)?
What is the 3-year average PE Ratio for ABVC BioPharma, Inc. (ABVC)?
What is the 5-year average PE Ratio for ABVC BioPharma, Inc. (ABVC)?
How does the current PE Ratio for ABVC BioPharma, Inc. (ABVC) compare to its historical average?